Yatin Suneja

Stock Analyst at Guggenheim

(5)
# 313
Out of 5,453 analysts
160
Total ratings
Success rate
Average return
47 Stocks
Name Action PT Current % Upside Ratings Updated
FBRX Forte Biosciences
Initiates Coverage On: Buy
75
11 581.82% 1 Aug 18, 2025
TRML Tourmaline Bio
Reiterates: Buy
55 55
23.46 134.44% 3 Aug 14, 2025
REGN Regeneron Pharmaceut...
Maintains: Strong Buy
810 815
590.65 37.98% 7 Aug 4, 2025
NBIX Neurocrine Bioscienc...
Maintains: Strong Buy
165 175
135.35 29.29% 6 Aug 1, 2025
ARGX argenx
Maintains: Strong Buy
1060 1070
662.61 61.48% 12 Aug 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
50 101
77 31.17% 2 Jul 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
26 26
3.94 559.9% 6 Jun 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Buy
18
4.73 280.55% 2 Jun 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
54 90
20.23 344.88% 13 May 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
23 25
1.63 1433.74% 5 May 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
32 29
13.12 121.04% 1 May 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
18 12
11.76 2.04% 4 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
15 15
2.01 646.27% 2 Mar 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
7 10
0.92 986.96% 5 Mar 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
7 7
0.72 872.22% 1 Mar 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 8 Mar 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
84 84
24.26 246.25% 1 Mar 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
45 45
17.22 161.32% 3 Mar 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Mar 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 3 Jan 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
45 45
11.48 291.99% 3 Jan 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
20 20
25.68 -22.12% 6 Jan 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Dec 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
50 65
17.44 272.71% 1 Oct 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
155 170
48.14 253.14% 2 Aug 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 May 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
72 90
22.57 298.76% 4 Feb 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
110 125
119.76 4.38% 8 Feb 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
16 32
n/a n/a 3 Jan 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Dec 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
17 16
11.93 34.12% 2 Nov 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
70 77
55.67 38.32% 3 Nov 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Sep 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Jul 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
49
38.84 26.16% 2 Jun 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
52 55
11.99 358.72% 2 May 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
270 350
138.95 151.89% 3 May 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
225 200
199.92 0.04% 3 Apr 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 5 Jan 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
98 117
116.3 0.17% 1 Dec 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
75
172.36 -56.49% 1 Oct 19, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Oct 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
24
14.98 60.21% 1 May 31, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Apr 26, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
29 34
105.56 -67.79% 2 Jan 14, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
n/a
n/a n/a 1 Feb 22, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
60 80
228.74 -65.03% 2 Jun 11, 2018